News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Clinical

Latest News

May 27th 2016

Major Cost Drivers in T2D Management

Updates to Treatment Guidelines: Effects on Payers

Advantages of Medications that Treat Multiple Conditions

Management of Hyperlipidemia in Patients With Liver Impairment or Renal Impairment

Considerations Regarding Statin Therapy

Latest Videos

Shared Decision-Making in Diabetes

Shared Decision-Making in Diabetes

Cost-Effectiveness and Coverage Decisions in Diabetes

Cost-Effectiveness and Coverage Decisions in Diabetes

Big Data Analysis and Clinical Decision Making in Diabetes

Big Data Analysis and Clinical Decision Making in Diabetes

Designing Better Cardiovascular Outcomes Trials in Diabetes

Designing Better Cardiovascular Outcomes Trials in Diabetes

Big Data and CVD Benefits of Anti-Diabetes Medications

Big Data and CVD Benefits of Anti-Diabetes Medications

Understanding Heart Failure in Diabetes

Understanding Heart Failure in Diabetes

Cardiovascular Outcomes Trials With Anti-Diabetes Medications

Cardiovascular Outcomes Trials With Anti-Diabetes Medications

SGLT2 Inhibition and CVD Outcomes in Type 2 Diabetes

SGLT2 Inhibition and CVD Outcomes in Type 2 Diabetes

Cardiovascular Outcomes With GLP-1 Receptor Agonists in Type 2 Diabetes

Cardiovascular Outcomes With GLP-1 Receptor Agonists in Type 2 Diabetes

Impact of the EMPA-REG Study in Type 2 Diabetes

Impact of the EMPA-REG Study in Type 2 Diabetes

CME Content

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

More News

Role of Clinical Practice Guidelines in the Management of Diabetes and Diabetes-Related Complications

May 27th 2016

Addressing the Effect of Polypharmacy on Medication Adherence

May 27th 2016

The Role of Managed Care in Identifying and Counseling Patients With Prediabetes

May 27th 2016

Partnering With Providers to Prevent or Delay Complications Related to Diabetes

May 27th 2016

WellCare's Initiatives To Improve Care for Members With Diabetes

May 27th 2016

Alternatives to Add-On Therapy for T2D and Hyperlipidemia

May 27th 2016

The Influence of Lipid Guidelines on Real-World Practice Patterns

May 27th 2016

Variables Involved When Adding Medications to Treat Diabetes

May 27th 2016

How Does the Potential for Weight Gain Influence Choice of Therapies?

May 27th 2016

Comparison of Guidelines From ADA and AACE

May 27th 2016

Complications of Diabetes and Role of Insulin Resistance in Metabolic Syndrome

May 27th 2016

BMS Piqued by ICER's HTA Report on New Myeloma Drugs, Publishes Response

BySurabhi Dangi-Garimella, PhD

May 26th 2016

Bristol-Myers Squibb has challenged the recently released report by the Institute for Clinical and Economic Review that evaluates the clinical and cost effectiveness of newer treatments for multiple myeloma.

"It Takes a Village" to Tackle the Diabetes Epidemic

May 26th 2016

What Is the Role of the Provider in Guiding People to Better Adherence?

May 26th 2016

Using Apps to Help Patients Manage Diabetes

May 26th 2016

How Can We Align Financing Incentives With Quality?

May 26th 2016

Why Recent Clinical Trials Make This a "Very Exciting Time" in Diabetes Care

May 26th 2016

Using Guidelines to Overcome Clinical Inertia

May 26th 2016

The Pharmacist as a Member of the Managed Care Team

May 26th 2016

Navigating the Evidence: From Clinical Trial to Clinical Practice

May 26th 2016

Engaging the Community to Promote Population Health

May 26th 2016

The Patient-Centered Medical Home in Diabetes Care

May 26th 2016

How Do We Evaluate Cardiovascular Risk in Diabetes?

May 26th 2016

Overview of the Diabetes Burden

May 26th 2016

Lowering Blood Pressure Among Older Patients Reduces Risk of Heart Failure

May 26th 2016

A new trial from the National Institutes of Health found that a lower systolic blood pressure goal of 120 mm Hg reduces risk of cardiovascular events in geriatric populations.

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

5 Things to Know About the Oral GLP-1 Era

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text